Humana Inc. (NYSE:HUM) Shares Sold by New Age Alpha Advisors LLC

New Age Alpha Advisors LLC cut its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 11.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,380 shares of the insurance provider's stock after selling 1,285 shares during the quarter. New Age Alpha Advisors LLC's holdings in Humana were worth $2,747,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in HUM. Applied Finance Capital Management LLC lifted its holdings in Humana by 1.7% during the 1st quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock valued at $779,000 after purchasing an additional 48 shares during the last quarter. Achmea Investment Management B.V. lifted its holdings in shares of Humana by 0.5% in the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock worth $2,746,000 after acquiring an additional 49 shares during the last quarter. Beech Hill Advisors Inc. increased its holdings in Humana by 6.1% in the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock worth $229,000 after purchasing an additional 50 shares in the last quarter. Deseret Mutual Benefit Administrators lifted its holdings in shares of Humana by 15.8% during the first quarter. Deseret Mutual Benefit Administrators now owns 462 shares of the insurance provider's stock worth $122,000 after purchasing an additional 63 shares during the period. Finally, Sound View Wealth Advisors Group LLC increased its position in Humana by 5.8% during the 1st quarter. Sound View Wealth Advisors Group LLC now owns 1,154 shares of the insurance provider's stock valued at $305,000 after purchasing an additional 63 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Analyst Ratings Changes

Several research firms have weighed in on HUM. Bank of America lowered their price objective on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a report on Tuesday, June 17th. Raymond James Financial raised Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price on the stock in a research note on Thursday, May 1st. Wall Street Zen cut shares of Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 price target on shares of Humana in a research note on Thursday, May 1st. Finally, Piper Sandler decreased their price objective on shares of Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a report on Thursday, July 31st. Seventeen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $281.62.

Humana Price Performance

HUM stock traded up $10.51 during mid-day trading on Friday, hitting $266.65. The company had a trading volume of 1,678,249 shares, compared to its average volume of 1,999,296. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $382.72. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a 50-day moving average price of $237.88 and a 200 day moving average price of $254.38. The company has a market capitalization of $32.07 billion, a price-to-earnings ratio of 20.46, a P/E/G ratio of 1.51 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. During the same period last year, the company earned $6.96 EPS. The business's revenue was up 9.6% compared to the same quarter last year. On average, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.